Featured Research

from universities, journals, and other organizations

Can-do plan gets women trimmer, healthier, cuts hot flashes

Date:
February 13, 2014
Source:
The North American Menopause Society (NAMS)
Summary:
A woman can beat middle-aged spread, her disease risks, and her hot flashes with the help of her healthcare provider. And even a short term program can spell success for women and fit into a busy provider's practice, shows a demonstration obesity-fighting and health risk reduction program detailed in an article just published.

A woman can beat middle-aged spread, her disease risks, and her hot flashes with the help of her healthcare provider. And even a short term program can spell success for women and fit into a busy provider's practice, shows a demonstration obesity-fighting and health risk reduction program detailed in an article just published online in Menopause, the journal of The North American Menopause Society (NAMS).

Making lifestyle changes can take a lot of work. Programs that have successfully helped women lose weight and reduce their other heart disease risks have been long and intensive -- and they work as long as the program goes on. Most first-line women's healthcare providers, such as obstetrician-gynecologists or primary care providers, don't have the time and might not be reimbursed for so many consultations.

But this pilot program, called WAIPointes (WAI stands for "who am I"), took only five visits that all were reimbursed by insurance. And it kept the participants engaged in achieving their health goals by showing them that they could reduce their menopause symptoms, in addition to their long-term disease risks, with healthy lifestyle changes.

The 83 women who completed the 6-month program ranged from 35 to 55 years old, and most were in perimenopause or menopause. At an orientation, the women learned about menopause and the health risks that come with it and were told they have the opportunity to get their personal health risks assessed if they joined the program. At the first visit, they answered questionnaires and got assessments of body weight and fat and menopause status and went home with a pedometer and a health diary, educational materials, and goal-setting worksheets to develop their personal health goals. From the second to the fifth visit, each woman had health assessments including waist measurement, blood pressure, menopause symptoms, mammograms and bone density tests if needed, and blood tests to look for inflammation, high cholesterol, and diabetes.

Once a woman had her goals set, she discussed with the healthcare providers how to reach those goals, what obstacles stood in the way, and how to overcome them. If distressing menopause symptoms were obstacles, the providers offered the women treatment options, such as lifestyle modifications or medications, to overcome them.

"Empowerment through education is a cornerstone of our intervention," wrote the authors. Their surveys of the participants and the health assessments showed that approach was working.

By the end of the program, the women understood their health risks better, and they had already made significant progress toward achieving their health goals. They trimmed their waistlines by an average of an inch and a half and lowered their diastolic blood pressure by 2 points. What's more, their hot flashes and other menopause symptoms, such as energy, libido, mood, and vaginal dryness, had all improved significantly. And each woman had a "life action plan," with personalized recommendations, to continue working toward their health goals.


Story Source:

The above story is based on materials provided by The North American Menopause Society (NAMS). Note: Materials may be edited for content and length.


Journal Reference:

  1. Diana L. Bitner, Robert A. Wild. Clinical intervention to reduce central obesity and menopausal symptoms in women aged 35 to 55 years. Menopause, 2014; 1 DOI: 10.1097/GME.0000000000000207

Cite This Page:

The North American Menopause Society (NAMS). "Can-do plan gets women trimmer, healthier, cuts hot flashes." ScienceDaily. ScienceDaily, 13 February 2014. <www.sciencedaily.com/releases/2014/02/140213112819.htm>.
The North American Menopause Society (NAMS). (2014, February 13). Can-do plan gets women trimmer, healthier, cuts hot flashes. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140213112819.htm
The North American Menopause Society (NAMS). "Can-do plan gets women trimmer, healthier, cuts hot flashes." ScienceDaily. www.sciencedaily.com/releases/2014/02/140213112819.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins